CHICAGO--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a leading, endocrine and rare disease biopharmaceutical company committed to helping people realize better lives through the development and ...
HEALTH Magazine on MSN
Metabolic syndrome: the chief health disruptor
Dr Rita Nawar, an endocrinologist with the American Academy of Cosmetic Surgery Hospital at Dubai Health Care City, gives a ...
33mon MSNOpinion
New precision medicine offers hope for breast cancer | Opinion
Precision medicine is transforming breast cancer care by using genetic testing to tailor treatments for patients.
GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. Georgiamune to receive $45 million in upfront and near-term ...
Daiichi Sankyo Highlights Ongoing Progress Across Industry-Leading ADC Portfolio with New Research Updates at ESMO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results